USD 24.55
↑ 1.03 (4.38%)
| ticker | 1 day return % | 1 week return % | 1 month return % | 3 months return % | 6 months return % | 1 year return % | 3 years return % | 5 years return % | 10 years return % | maximum return % |
|---|---|---|---|---|---|---|---|---|---|---|
| GPS | 0 | 17.7 | 4.4 | -2.6 | -9.0 | 150 | 3.1 | 42.8 | -43.2 | 22464.3 |
| S&P 500 | -0.6 | -0.5 | 1.5 | 9.1 | 13.4 | 32.3 | 27.0 | 92.1 | 191.7 | 33587.3 |
Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline
Feel free to experiment with these tools to enhance your technical analysis. Remember, any drawings you make are temporary and will be lost upon refreshing the page unless saved as an image using the 'Camera' icon.
Get instant AI-powered professional insights on prices:
💡Generate AI Technical Analysis ReportA Multi-Interval Candlestick Chart displays the price movements of an asset over different time intervals. Each candlestick represents the open, high, low, and close prices for a specific interval. The chart can be used to identify trends and patterns in price movements.
| Attribute | Value |
|---|---|
| symbol | GPS |
| name | The Gap, Inc. |
| price | 24.55 |
| changes percentage | 4.3793 |
| change | 1.03 |
| day low | 23.77 |
| day high | 24.65 |
| year high | 30.75 |
| year low | 9.71 |
| market cap | 9207895046 |
| price avg 50 | 22.9668 |
| price avg 200 | 22.24185 |
| exchange | NYSE |
| volume | 6166831 |
| avg volume | 6774470 |
| open | 24.5 |
| previous close | 23.52 |
| eps | 1.8 |
| pe | 13.638889 |
| earnings announcement | 2024-11-14T00:00:00.000+0000 |
| shares outstanding | 375067008 |
| timestamp | 2024-08-21 20:00:02 |
We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.
| 2023 | 2022 | Y/Y change % | |
|---|---|---|---|
| 0000039911 | |||
| revenue | 14889000000 | 15616000000 | -4.66 |
| gross profit | 5761000000 | 5359000000 | 7.50 |
| gross profit ratio | 0.39 | 0.34 | 12.75 |
| research and development expenses | 37000000 | 46000000 | -19.57 |
| operating expenses | 5139000000 | 5428000000 | -5.32 |
| interest income | 86000000 | 18000000 | 377.78 |
| interest expense | 90000000 | 88000000 | 2.27 |
| ebitda | 1168000000 | 476000000 | 145.38 |
| ebitdaratio | 0.08 | 0.03 | 154.75 |
| operating income | 622000000 | -69000000 | 1001.45 |
| operating income ratio | 0.04 | -0.0 | 1045.47 |
| net income | 502000000 | -202000000 | 348.51 |
| net income ratio | 0.03 | -0.01 | 360.65 |
| eps | 1.36 | -0.55 | 347.27 |
Revenue Growth: revenue decreased to 14,889 million in 2023 from 15,616 million in 2022 representing a change of -4.66%. This indicates a sales shrinking, which is a negative sign for the company.
Research and Development (R&D) Expenses: R&D Expenses decreased to 37 million in 2023 from 46 million in 2022 representing a change of -19.57%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.
EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 1,168 million in 2023 from 476 million in 2022 representing a change of 145.38%. The decrease in EBITDA indicates declined operational efficiency and profitability.
Gross Profit: Gross Profit increased to 5,761 million in 2023 from 5,359 million in 2022 representing a change of 7.5%. This indicates a sales profitability growth, which is a positive sign for the company.
Operating Expenses: Operating Expenses decreased to 5,139 million in 2023 from 5,428 million in 2022 representing a change of -5.32%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.
Operating Income: Operating income increased to 622 million in 2023 from -69 million in 2022 representing a change of 1001.45%. The increase in operating income indicates better operational performance and increased profitability.
Net Income: Net income increased to 502 million in 2023 from -202 million in 2022 representing a change of 348.51%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.
Earnings per Share (EPS): EPS increased to 1.36 in 2023 from 1.36 in 2022 representing a change of 347.27%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.
| 2024Q2 | 2024Q1 | Q/Q change % | |
|---|---|---|---|
| 0000039911 | |||
| revenue | 3720000000 | 3388000000 | 9.80 |
| gross profit | 1583000000 | 1399000000 | 13.15 |
| gross profit ratio | 0.43 | 0.41 | 3.05 |
| research and development expenses | 0 | 0 | NaN |
| operating expenses | 1290000000 | 1185000000 | 8.86 |
| interest income | 27000000 | 24000000 | 12.50 |
| interest expense | 24000000 | 21000000 | 14.29 |
| ebitda | 443000000 | 353000000 | 25.50 |
| ebitdaratio | 0.12 | 0.1 | 19.37 |
| operating income | 293000000 | 214000000 | 36.92 |
| operating income ratio | 0.08 | 0.06 | 24.70 |
| net income | 206000000 | 158000000 | 30.38 |
| net income ratio | 0.06 | 0.05 | 18.74 |
| eps | 0.55 | 0.42 | 30.95 |
Revenue Growth: revenue increased to 3,720 million in 2024Q2 from 3,388 million in 2024Q1 representing a change of 9.8%. This indicates a sales growth, which is a positive sign for the company.
Gross Profit: Gross Profit increased to 1,583 million in 2024Q2 from 1,399 million in 2024Q1 representing a change of 13.15%. This indicates a sales profitability growth, which is a positive sign for the company.
EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 443 million in 2024Q2 from 353 million in 2024Q1 representing a change of 25.5%. The increase in EBITDA indicates improved operational efficiency and profitability.
Operating Income: Operating income increased to 293 million in 2024Q2 from 214 million in 2024Q1 representing a change of 36.92%. The increase in operating income indicates better operational performance and increased profitability.
Net Income: Net income increased to 206 million in 2024Q2 from 158 million in 2024Q1 representing a change of 30.38%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.
Earnings per Share (EPS): EPS increased to 0.55 in 2024Q2 from 0.55 in 2024Q1 representing a change of 30.95%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.
Operating Expenses: Operating Expenses increased to 1,290 million in 2024Q2 from 1,185 million in 2024Q1 representing a change of 8.86%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.
| 2023 | 2022 | Y/Y change % | |
|---|---|---|---|
| 0000039911 | |||
| total assets | 11044000000 | 11386000000 | -3.00 |
| total liabilities | 8449000000 | 9153000000 | -7.69 |
| total equity | 2595000000 | 2233000000 | 16.21 |
| cash and cash equivalents | 1872000000 | 1215000000 | 54.07 |
| short term investments | 1000000 | 15000000 | -93.33 |
| long term investments | 32000000 | 26000000 | 23.08 |
| total current assets | 4395000000 | 4617000000 | -4.81 |
| total non current assets | 6649000000 | 6769000000 | -1.77 |
| total current liabilities | 3096000000 | 3256000000 | -4.91 |
| total non current liabilities | 5353000000 | 5897000000 | -9.23 |
| common stock | 19000000 | 18000000 | 5.56 |
| retained earnings | 2420000000 | 2140000000 | 13.08 |
| total debt | 5441000000 | 6020000000 | -9.62 |
Total Assets: Total Assets decreased to 11,044 million in 2023 from 11,386 million in 2022 representing a change of -3.0%. Suggesting a decrease in asset holdings.
Short Term Investments: Short Term Investments decreased to 1 million in 2023 from 15 million in 2022 representing a change of -93.33%. This indicates a decrease in short-term investment holdings.
Total Current Assets: Total Current Assets decreased to 4,395 million in 2023 from 4,617 million in 2022 representing a change of -4.81%. This indicates a worsen liquidity position.
Total Liabilities: Total Liabilities decreased to 8,449 million in 2023 from 9,153 million in 2022 representing a change of -7.69%. This indicates a decrease in overall liabilities.
Total Equity: Total Equity increased to 2,595 million in 2023 from 2,233 million in 2022 representing a change of 16.21%. This indicates an increase in shareholders' equity.
Cash And Cash Equivalents: Cash And Cash Equivalents increased to 1,872 million in 2023 from 1,215 million in 2022 representing a change of 54.07%. This indicates an increase in available liquid assets.
Total Current Liabilities: Total Current Liabilities decreased to 3,096 million in 2023 from 3,256 million in 2022 representing a change of -4.91%. This indicates a lower short-term debt burden.
Common Stock: Common Stock increased to 19 in 2023 from 18 in 2022 representing a change of 5.56%. This indicates an increase in ownership interest.
Retained Earnings: Retained Earnings increased to 2,420 million in 2023 from 2,140 million in 2022 representing a change of 13.08%. This indicates an accumulated profits.
Total Debt: Total Debt decreased to 5,441 million in 2023 from 6,020 million in 2022 representing a change of -9.62%. This indicates a reduction in overall debt burden.
| 2024Q2 | 2024Q1 | Q/Q change % | |
|---|---|---|---|
| 0000039911 | |||
| total assets | 11509000000 | 10908000000 | 5.51 |
| total liabilities | 8608000000 | 8201000000 | 4.96 |
| total equity | 2901000000 | 2707000000 | 7.17 |
| cash and cash equivalents | 1900000000 | 1532000000 | 24.02 |
| short term investments | 246000000 | 199000000 | 23.62 |
| long term investments | 0 | 29000000 | -100.00 |
| total current assets | 4809000000 | 4197000000 | 14.58 |
| total non current assets | 6700000000 | 6711000000 | -0.16 |
| total current liabilities | 3224000000 | 2806000000 | 14.90 |
| total non current liabilities | 5384000000 | 5395000000 | -0.20 |
| common stock | 19000000 | 19000000 | 0.00 |
| retained earnings | 2672000000 | 2522000000 | 5.95 |
| total debt | 5459000000 | 5500000000 | -0.75 |
Total Assets: Total Assets increased to 11,509 million in 2024Q2 from 10,908 million in 2024Q1 representing a change of 5.51%. Suggesting a growth in asset holdings.
Total Equity: Total Equity increased to 2,901 million in 2024Q2 from 2,707 million in 2024Q1 representing a change of 7.17%. This indicates an increase in shareholders' equity.
Cash And Cash Equivalents: Cash And Cash Equivalents increased to 1,900 million in 2024Q2 from 1,532 million in 2024Q1 representing a change of 24.02%. This indicates an increase in available liquid assets.
Short Term Investments: Short Term Investments increased to 246 million in 2024Q2 from 199 million in 2024Q1 representing a change of 23.62%. This indicates an increase in short-term investment holdings.
Total Current Assets: Total Current Assets increased to 4,809 million in 2024Q2 from 4,197 million in 2024Q1 representing a change of 14.58%. This indicates a better liquidity position.
Retained Earnings: Retained Earnings increased to 2,672 million in 2024Q2 from 2,522 million in 2024Q1 representing a change of 5.95%. This indicates an accumulated profits.
Total Debt: Total Debt decreased to 5,459 million in 2024Q2 from 5,500 million in 2024Q1 representing a change of -0.75%. This indicates a reduction in overall debt burden.
Total Liabilities: Total Liabilities increased to 8,608 million in 2024Q2 from 8,201 million in 2024Q1 representing a change of 4.96%. This indicates an increase in overall liabilities.
Total Current Liabilities: Total Current Liabilities increased to 3,224 million in 2024Q2 from 2,806 million in 2024Q1 representing a change of 14.9%. This indicates a higher short-term debt burden.
| 2023 | 2022 | Y/Y change % | |
|---|---|---|---|
| 0000039911 | |||
| net change in cash | 640000000 | 371000000 | 72.51 |
| operating cash flow | 1532000000 | 607000000 | 152.39 |
| free cash flow | 1112000000 | -78000000 | 1525.64 |
| capital expenditure | -420000000 | -685000000 | 38.69 |
| depreciation and amortization | 522000000 | 540000000 | -3.33 |
| deferred income tax | -64000000 | 42000000 | -252.38 |
| stock based compensation | 80000000 | 37000000 | 116.22 |
| accounts payables | 42000000 | -540000000 | 107.78 |
| inventory | 383000000 | 554000000 | -30.87 |
| acquisitions net | 85000000 | 458000000 | -81.44 |
| investments in property plant and equipment | -420000000 | -685000000 | 38.69 |
| net cash used for investing activites | -334000000 | -227000000 | -47.14 |
| debt repayment | -350000000 | 350000000 | -200.00 |
| common stock issued | 27000000 | 0 | NaN |
| common stock repurchased | -20000000 | -123000000 | 83.74 |
| dividends paid | -222000000 | -220000000 | -0.91 |
| net cash used provided by financing activities | -567000000 | 6000000 | -9550.00 |
| cash at end of period | 1872000000 | 1273000000 | 47.05 |
| accounts receivables | 0 | 0 | NaN |
| cash at beginning of period | 1232000000 | 902000000 | 36.59 |
Net Change in Cash: Net Change in Cash increased to 640 million in 2023 from 371 million in 2022 representing a change of 72.51%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.
Operating Cash Flow: Operating Cash Flow increased to 1,532 million in 2023 from 607 million in 2022 representing a change of 152.39%. This indicates that the company generated more cash from its core business operations.
Free Cash Flow: Free Cash Flow increased to 1,112 million in 2023 from -78 million in 2022 representing a change of 1525.64%. This indicates an increase in cash generated after accounting for capital expenditures.
Accounts Payables: The absolute value of Accounts Payables decreased to 42 million in 2023 from 540 million in 2022 representing a change of 107.78%. This indicates that the company has reduced its outstanding obligations to its suppliers.
Capital Expenditure: Capital Expenditure increased to -420 million in 2023 from -685 million in 2022 representing a change of 38.69%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.
Stock-Based Compensation: Stock-Based Compensation increased to 80 million in 2023 from 37 million in 2022 representing a change of 116.22%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.
Dividends Paid: Dividends Paid decreased to -222 million in 2023 from -220 million in 2022 representing a change of -0.91%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.
| 2024Q2 | 2024Q1 | Q/Q change % | |
|---|---|---|---|
| 0000039911 | |||
| operating cash flow | 549000000 | 30000000 | 1730.00 |
| free cash flow | 460000000 | -63000000 | 830.16 |
| capital expenditure | -89000000 | -93000000 | 4.30 |
| depreciation and amortization | 123000000 | 124000000 | -0.81 |
| deferred income tax | -9000000 | 1000000 | -1000.00 |
| stock based compensation | 31000000 | 27000000 | 14.81 |
| accounts receivables | 0 | 0 | NaN |
| accounts payables | 307000000 | -152000000 | 301.97 |
| inventory | -156000000 | 38000000 | -510.53 |
| acquisitions net | 0 | 0 | NaN |
| investments in property plant and equipment | -89000000 | -93000000 | 4.30 |
| net cash used for investing activites | -134000000 | -291000000 | 53.95 |
| debt repayment | 0 | 0 | NaN |
| common stock issued | 0 | 10000000 | -100.00 |
| common stock repurchased | 0 | -31000000 | 100.00 |
| dividends paid | -56000000 | -56000000 | 0.00 |
| net cash used provided by financing activities | -47000000 | -77000000 | 38.96 |
| net change in cash | 368000000 | -340000000 | 208.24 |
| cash at end of period | 1929000000 | 1532000000 | 25.91 |
| cash at beginning of period | 1561000000 | 1872000000 | -16.61 |
Net Change in Cash: Net Change in Cash increased to 368 million in 2024Q2 from -340 million in 2024Q1 representing a change of 208.24%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.
Operating Cash Flow: Operating Cash Flow increased to 549 million in 2024Q2 from 30 million in 2024Q1 representing a change of 1730.0%. This indicates that the company generated more cash from its core business operations.
Free Cash Flow: Free Cash Flow increased to 460 million in 2024Q2 from -63 million in 2024Q1 representing a change of 830.16%. This indicates an increase in cash generated after accounting for capital expenditures.
Capital Expenditure: Capital Expenditure increased to -89 million in 2024Q2 from -93 million in 2024Q1 representing a change of 4.3%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.
Stock-Based Compensation: Stock-Based Compensation increased to 31 million in 2024Q2 from 27 million in 2024Q1 representing a change of 14.81%. This indicates increased expenses, which is generally considered a negative sign from a financial perspective.
Accounts Payables: The absolute value of Accounts Payables increased to 307 million in 2024Q2 from 152 million in 2024Q1 representing a change of 301.97%. This indicates that the company has increased its outstanding obligations to its suppliers.
We save you time by utilizing Generative AI to summarize earnings transcripts. Our summaries provide a clear insight into the company's current performance, future outlook, and overall sentiment expressed during the call. Click on below links to explore more.
Note: The years mentioned below are fiscal years in accounting.
Q2 2024 Earnings call transcript
EPS represents the portion of a company's profit allocated to each outstanding share of common stock. A higher EPS is generally favorable, indicating stronger profitability on a per-share basis.
Positive EPS: A positive EPS signifies that a company is profitable, it is generally viewed positively, supporting stock value and investor confidence.
Negative EPS: Indicates that a company is operating at a loss, which could lead to negative sentiment, potential stock depreciation, and concerns about the company's financial health.
The Next Earning Date represents when the company plans to release its next set of financial results.
An upward trend in EPS suggests consistent growth in earnings, often leading to increased investor confidence. A downward trend may indicate a decline in earnings, potentially decreasing investor confidence and stock value. Fluctuating EPS suggests unpredictable financial performance, warranting cautious investor analysis.
Earnings surprise occurs when a company's actual earnings differ from analysts' expectations. A positive earnings surprise typically reflects better-than-expected performance, potentially leading to stock appreciation. Conversely, a negative earnings surprise can result in stock depreciation. An earnings surprise of zero means the earnings met expectations, which typically has a neutral impact on stock price.
Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.
| 2024-02-03 | 2023-01-28 | Y/Y change % | |
|---|---|---|---|
| FY | |||
| calendar year | 2023 | 2022 | NaN |
| revenue per share | 40.24 | 42.55 | -5.43 |
| net income per share | 1.36 | -0.55 | 346.50 |
| operating cash flow per share | 4.14 | 1.65 | 150.34 |
| free cash flow per share | 3.01 | -0.21 | 1514.08 |
| cash per share | 5.06 | 3.35 | 51.04 |
| book value per share | 7.01 | 6.08 | 15.27 |
| tangible book value per share | 6.26 | 5.3 | 18.11 |
| shareholders equity per share | 7.01 | 6.08 | 15.27 |
| interest debt per share | 5.89 | 7.06 | -16.62 |
| market cap | 7329700000 | 4844400000 | 51.30 |
| enterprise value | 10898700000 | 9649400000 | 12.95 |
| pe ratio | 14.6 | -23.98 | 160.88 |
| price to sales ratio | 0.49 | 0.31 | 58.69 |
| pocfratio | 4.78 | 7.98 | -40.05 |
| pfcf ratio | 6.59 | -62.11 | 110.61 |
| pb ratio | 2.82 | 2.17 | 30.20 |
| ptb ratio | 2.82 | 2.17 | 30.20 |
| ev to sales | 0.73 | 0.62 | 18.46 |
| enterprise value over ebitda | 9.33 | 20.27 | -53.97 |
| ev to operating cash flow | 7.11 | 15.9 | -55.25 |
| ev to free cash flow | 9.8 | -123.71 | 107.92 |
| earnings yield | 0.07 | -0.04 | 264.25 |
| free cash flow yield | 0.15 | -0.02 | 1042.25 |
| debt to equity | 0.8 | 1.12 | -28.22 |
| debt to assets | 0.19 | 0.22 | -14.00 |
| net debt to ebitda | 3.06 | 10.09 | -69.73 |
| current ratio | 1.42 | 1.42 | 0.11 |
| interest coverage | 6.91 | -0.78 | 981.42 |
| income quality | 3.05 | -3.0 | 201.56 |
| dividend yield | 0.03 | 0.05 | -33.31 |
| payout ratio | 0.44 | -1.09 | 140.60 |
| sales general and administrative to revenue | 0.28 | 0.28 | 2.24 |
| research and ddevelopement to revenue | 0.0 | 0.0 | -15.64 |
| intangibles to total assets | 0.03 | 0.03 | -0.13 |
| capex to operating cash flow | 0.27 | 1.13 | -75.71 |
| capex to revenue | 0.03 | 0.04 | -35.69 |
| capex to depreciation | 0.8 | 1.27 | -36.57 |
| stock based compensation to revenue | 0.01 | 0.0 | 126.77 |
| graham number | 14.63 | 8.68 | 68.56 |
| roic | 0.12 | -0.02 | 666.40 |
| return on tangible assets | 0.05 | -0.02 | 356.20 |
| graham net net | -14.49 | -17.64 | 17.85 |
| working capital | 1299000000 | 1361000000 | -4.56 |
| tangible asset value | 2316000000 | 1945000000 | 19.07 |
| net current asset value | -4054000000 | -4536000000 | 10.63 |
| invested capital | 7259000000 | 7510000000 | -3.34 |
| average receivables | 314500000 | 369500000 | -14.88 |
| average payables | 1334500000 | 1635500000 | -18.40 |
| average inventory | 2192000000 | 2703500000 | -18.92 |
| days sales outstanding | 7.08 | 7.95 | -10.85 |
| days payables outstanding | 53.94 | 46.97 | 14.84 |
| days of inventory on hand | 79.77 | 85.01 | -6.16 |
| receivables turnover | 51.52 | 45.93 | 12.17 |
| payables turnover | 6.77 | 7.77 | -12.92 |
| inventory turnover | 4.58 | 4.29 | 6.57 |
| roe | 0.19 | -0.09 | 313.85 |
| capex per share | 1.14 | 1.87 | -39.18 |
ROE: Return on Equity (ROE) increased to 0.19 on 2024-02-03 from -0.09 on 2023-01-28, representing a change of 313.85%. Suggesting the company has been generating high returns for its shareholders.
PE Ratio: Price-to-Earnings (P/E) Ratio increased to 14.60 on 2024-02-03 from -23.98 on 2023-01-28, representing a change of 160.88%. Indicating an increase in the relative valuation of the company's stock.
Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.80 on 2024-02-03 from 1.12 on 2023-01-28, representing a change of -28.22%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.
Current Ratio: Current Ratio decreased to 1.42 on 2024-02-03 from 1.42 on 2023-01-28, representing a change of 0.11%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.
| 2024-08-03 Q2 | 2024-05-04 Q1 | Q/Q change % | |
|---|---|---|---|
| GPS | |||
| calendar year | 2024 | 2024 | NaN |
| revenue per share | 9.89 | 9.06 | 9.22 |
| net income per share | 0.55 | 0.42 | 29.69 |
| operating cash flow per share | 1.46 | 0.08 | 1720.27 |
| free cash flow per share | 1.22 | -0.17 | 826.27 |
| cash per share | 5.71 | 4.63 | 23.32 |
| book value per share | 7.72 | 7.24 | 6.60 |
| tangible book value per share | 7.72 | 7.24 | 6.60 |
| shareholders equity per share | 7.72 | 7.24 | 6.60 |
| interest debt per share | 4.02 | 5.71 | -29.48 |
| market cap | 8159200000 | 8074660000 | 1.05 |
| enterprise value | 11718200000 | 12042660000 | -2.69 |
| pe ratio | 9.9 | 12.78 | -22.50 |
| price to sales ratio | 2.19 | 2.38 | -7.97 |
| pocfratio | 14.86 | 269.16 | -94.48 |
| pfcf ratio | 17.74 | -128.17 | 113.84 |
| pb ratio | 2.81 | 2.98 | -5.71 |
| ptb ratio | 2.81 | 2.98 | -5.71 |
| ev to sales | 3.15 | 3.55 | -11.38 |
| enterprise value over ebitda | 26.45 | 34.12 | -22.46 |
| ev to operating cash flow | 21.34 | 401.42 | -94.68 |
| ev to free cash flow | 25.47 | -191.15 | 113.33 |
| earnings yield | 0.03 | 0.02 | 29.03 |
| free cash flow yield | 0.06 | -0.01 | 822.59 |
| debt to equity | 0.51 | 0.78 | -34.24 |
| debt to assets | 0.13 | 0.19 | -33.21 |
| net debt to ebitda | 8.03 | 11.24 | -28.53 |
| current ratio | 1.49 | 1.5 | -0.27 |
| interest coverage | 12.21 | 10.19 | 19.80 |
| income quality | 2.67 | 0.19 | 1303.59 |
| dividend yield | 0.01 | 0.01 | -1.04 |
| payout ratio | 0.27 | 0.35 | -23.30 |
| sales general and administrative to revenue | 0 | 0 | NaN |
| research and ddevelopement to revenue | 0 | 0 | NaN |
| intangibles to total assets | 0 | 0 | NaN |
| capex to operating cash flow | 0.16 | 3.1 | -94.77 |
| capex to revenue | 0.02 | 0.03 | -12.84 |
| capex to depreciation | 0.72 | 0.75 | -3.52 |
| stock based compensation to revenue | 0.01 | 0.01 | 4.57 |
| graham number | 9.75 | 8.29 | 17.58 |
| roic | 0.05 | 0.03 | 37.73 |
| return on tangible assets | 0.02 | 0.01 | 23.57 |
| graham net net | -14.38 | -14.69 | 2.08 |
| working capital | 1585000000 | 1391000000 | 13.95 |
| tangible asset value | 2901000000 | 2707000000 | 7.17 |
| net current asset value | -3799000000 | -4004000000 | 5.12 |
| invested capital | 7295000000 | 7126000000 | 2.37 |
| average receivables | 0 | 144500000 | -100.00 |
| average payables | 1359000000 | 1272500000 | 6.80 |
| average inventory | 2029500000 | 1973500000 | 2.84 |
| days sales outstanding | 0 | 0 | NaN |
| days payables outstanding | 64.1 | 54.12 | 18.44 |
| days of inventory on hand | 88.74 | 88.33 | 0.47 |
| receivables turnover | 0 | 0 | NaN |
| payables turnover | 1.4 | 1.66 | -15.57 |
| inventory turnover | 1.01 | 1.02 | -0.46 |
| roe | 0.07 | 0.06 | 21.66 |
| capex per share | 0.24 | 0.25 | -4.81 |
ROE:
PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 9.90 on 2024-08-03 Q2 from 12.78 on 2024-05-04 Q1, representing a change of -22.50%. Indicating a decrease in the relative valuation of the company's stock.
Current Ratio: Current Ratio decreased to 1.49 on 2024-08-03 Q2 from 1.50 on 2024-05-04 Q1, representing a change of -0.27%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.
Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.51 on 2024-08-03 Q2 from 0.78 on 2024-05-04 Q1, representing a change of -34.24%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.
Negative Sentiment: Discounted Cash Flow value is -1.13 which is lower than current price 24.55, indicates the company may be overvalued.
| Market Capitalization | Enterprise Value | |
|---|---|---|
| Definition | The total market value of a company's outstanding shares | The total market value of a company, including its debt and other liabilities |
| Calculation | Current share price * Total number of outstanding shares | Market capitalization + Total debt - Cash and cash equivalents |
| Focus | Equity component of a company's value | Total economic value of a company |
| Usefulness | Assesses a company's size and growth potential based on investor sentiment | Provides a more comprehensive valuation that considers both equity and debt |
Analyzing dividends is a crucial aspect of investment evaluation, offering valuable insights into a company's financial health and its commitment to shareholder returns. Dividends represent a portion of a company's profits distributed to its shareholders, providing a steady income stream. We help you analyze dividends based on the indicators mentioned below:
• Investors often assess the average dividend amount, observing trends over time to gauge the company's stability and growth potential. A positive trend in average dividends indicates a consistent and potentially lucrative investment. Additionally, evaluating the trend of dividend increases provides insight into the company's financial strength and management's confidence in future earnings.
• Consistency in paying dividends is a reassuring sign, reflecting a company's reliability and commitment to shareholder value. For investors, dividends not only offer income but also contribute to the overall total return on investment.
• Companies with a history of regular and increasing dividends can attract income-focused investors seeking stable returns, making dividends a critical factor in building a well-rounded investment portfolio.
Interested in the overall sentiment for a particular period? Check out our news sentiment analysis tool.
Sentiment: Positive
Publish Date: 2024-11-14 11:00:42
Gap (GAP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Sentiment: Positive
Publish Date: 2024-11-12 17:23:00
SAN FRANCISCO , Nov. 12, 2024 /PRNewswire/ -- Gap Inc. (NYSE: GAP) today announced its board of directors has authorized a fourth quarter fiscal year 2024 dividend of $0.15 per share, payable on or after January 29, 2025, to shareholders of record at the close of business on January 8, 2025. About Gap Inc. Gap Inc., a house of iconic brands, is the largest specialty apparel company in America.
Sentiment: Positive
Publish Date: 2024-11-12 13:11:09
Gap (GAP) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Sentiment: Positive
Publish Date: 2024-11-01 10:41:22
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Sentiment: Neutral
Publish Date: 2024-10-31 16:15:00
SAN FRANCISCO , Oct. 31, 2024 /PRNewswire/ -- Gap Inc. (NYSE: GAP) will report its third quarter fiscal 2024 financial results by press release on November 21, 2024, at approximately 1:15 p.m. Pacific Time.
Sentiment: Positive
Publish Date: 2024-10-29 15:28:00
WARREN, N.J., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T cell therapeutics to treat infectious disease and cancers, announced today that on October 28, 2024, it received written notice from the Listing Qualifications Staff of the Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company has regained compliance with the minimum bid price requirement (the “Minimum Bid Price Requirement”), as set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Global Market.
Sentiment: Positive
Publish Date: 2024-10-28 12:12:20
The Gap, Inc.'s Q3 report is important as the company needs to show continued progress in the recently successful brand turnaround. A weak consumer weighs on the Q3 outlook, causing a more moderate growth outlook, but GAP should still report good comparable results due to the good brand momentum. As the market has remained skeptical of GAP's turnaround despite the recent successful quarters, the stock now brings an attractive risk-to-reward.
Sentiment: Positive
Publish Date: 2024-10-25 10:45:25
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Sentiment: Positive
Publish Date: 2024-10-24 09:00:00
AI for Justice Legal Aid - Thomson Reuters announces first Legal Innovators Incubator class and subsidized CoCounsel pricing for legal aid organizations (LSOs). AI Policy Consortium - New initiatives bolster ongoing efforts such as the recently launched AI Policy Consortium for Law and Courts, a joint effort from Thomson Reuters Institute and the National Center for State Courts (NCSC).
Sentiment: Positive
Publish Date: 2024-10-23 11:33:35
I reiterate my hold rating for Moody's due to its valuation premium compared to S&P Global, despite strong fundamentals. MCO's 3Q24 earnings report showed impressive revenue and EPS growth, driven by strong performance in Moody's Investor Services (MIS) segment. The valuation gap between MCO and SPGI is closing, suggesting a more favorable entry point for patient investors may soon emerge.
Sentiment: Positive
Publish Date: 2024-10-21 13:15:17
GAP is well-positioned for long-term growth, supported by its strategic focus on improving brands and maintaining financial and operational rigor.
Sentiment: Positive
Publish Date: 2024-10-21 09:15:00
NextNav's Next-Generation 3D Terrestrial PNT Solution in Lower 900 MHz Band has Potential to Save US Economy $663 Million for One Day of a Global GPS Outage NextNav's Next-Generation 3D Terrestrial PNT Solution in Lower 900 MHz Band has Potential to Save US Economy $663 Million for One Day of a Global GPS Outage
Sentiment: Neutral
Publish Date: 2024-10-18 09:00:00
Note: Gap's FY'23 ended on February 3, 2024.
Sentiment: Positive
Publish Date: 2024-10-15 08:45:00
- GPS Currently Investigated in Phase 3 REGAL Trial in Adult AML Patients – Interim Analysis Anticipated in Q4 2024 - - RPDD Provides Eligibility for GPS to Receive a Priority Review Voucher (PRV) Upon Marketing Approval that can be Transferred/Sold to Other Parties – - Recent Valuations for PRVs Remain Attractive (~$100 million/each) – NEW YORK, Oct. 15, 2024 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today announced that the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease Designation (RPDD) to Galinpepimut-S (GPS), an immunotherapeutic targeting Wilms Tumor-1 (WT1), for the treatment of pediatric acute myeloid leukemia (AML). “GPS has already demonstrated promise in clinical settings for AML, and we believe its potential could extend to pediatric patients,” said Angelos Stergiou, MD, ScD h.c.
Sentiment: Positive
Publish Date: 2024-10-14 18:43:00
WARREN, N.J., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T cell therapeutics to treat infectious disease and cancers, plans to update shareholders on multi-billion dollar asset valuation following this week's $1b+ revenue potential announcement.
Sentiment: Positive
Publish Date: 2024-10-09 10:45:23
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Sentiment: Positive
Publish Date: 2024-10-08 23:00:00
HONG KONG , Oct. 8, 2024 /PRNewswire/ -- Yang Xu, Global Partner at leading global online brokerage Tiger Brokers, shared insights on how Bitcoin Exchange-Traded Funds (ETFs) are shaping the traditional finance industry while speaking at InnoBlock 2024, one of TOKEN2049's largest side events this year. Xu participated in a panel discussion titled Bitcoin ETFs and Traditional Finance: Bridging the Gap, where he shared that Bitcoin ETFs help to provide safer access to the underlying cryptocurrency while addressing several long-standing issues within the digital asset space, such as master custodian concerns.
Sentiment: Positive
Publish Date: 2024-10-07 10:56:21
The consensus price target hints at a 27.4% upside potential for Gap (GAP). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Sentiment: Positive
Publish Date: 2024-10-01 12:41:19
TomTom N.V. stands at a crossroads, leading in HD mapping and autonomous tech but struggling to compete with giants like Google and deliver consistent returns. Despite technological advancements and partnerships, TomTom's stock has declined 45% since 2020, underperforming the S&P 500 and offering no dividends. TomTom's Q2 2024 earnings highlight new product launches and partnerships, but the company faces significant financial and competitive challenges.
Sentiment: Positive
Publish Date: 2024-10-01 08:30:00
INBS announces the addition of GPS Marine, a leading provider of marine construction and logistics services, to its growing number of customer accounts.
* The sentiment analysis presented is generated through an algorithm and may be subject to inaccuracies. Users are advised to corroborate key information and employ further analytical methods prior to making critical decisions.
Get instant AI-powered professional insights:
💡Generate AI Technical Analysis ReportUnderstand the chart below:
Interpret Technical Indicators
| Indicator | Bullish | Bearish |
|---|---|---|
| Price and EMA ⓘ | Price crosses above EMA | Price crosses below EMA |
| Short-Term vs Long-Term EMA ⓘ | Short EMA crosses above Long EMA | Short EMA crosses below Long EMA |
| Volume ⓘ | Increasing volume during price uptrend | Increasing volume during price downtrend |
| MACD ⓘ | MACD crosses above Signal Line | MACD crosses below Signal Line |
| RSI ⓘ | RSI is below 30 (oversold) and starts to rise above 30 | RSI is above 70 (overbought) and starts to decline below 70 |
| Candlestick Patterns ⓘ | Bullish candlestick patterns | Bearish candlestick patterns |
Copyright © 2024 Sirius Investors
All rights reserved
